Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound buprenorphine sublingual tablets for opioid dependence maintenance
CTR20140010Phase 2Completed
- Sponsor
- Hebei Aoxing Pharmaceutical Group
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by Hebei Aoxing Pharmaceutical Group. Started Apr 2014; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on CTR20140010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140010.